Aigen Investment Management’s Prothena Corp PRTA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-9,901
Closed -$245K 971
2024
Q1
$245K Buy
+9,901
New +$295K 0.05% 496
2023
Q4
Sell
-34,890
Closed -$1.68M 1022
2023
Q3
$1.68M Buy
+34,890
New +$2.07M 0.32% 63
2023
Q2
Sell
-6,503
Closed -$315K 925
2023
Q1
$315K Buy
+6,503
New +$344K 0.04% 417
2020
Q4
Sell
-13,157
Closed -$131K 991
2020
Q3
$131K Buy
+13,157
New +$158K 0.02% 695

Other funds holding PRTA

Aigen Investment Management's PRTA Position: Q2 2024 in Review

Aigen Investment Management sold out of Prothena Corp (PRTA) in Q2 2024, closing a stake of 9,901 shares — an estimated $245K sold.

Aigen Investment Management first reported a position in PRTA in Q3 2020 and held it in 4 quarters. The position peaked at $1.68M in Q3 2023. 160 funds tracked by Wall St. Rank hold PRTA as of Q2 2024.

  • Aigen Investment Management reported no remaining Prothena Corp position as of Q2 2024 after selling out during the quarter.
  • Aigen Investment Management sold 9,901 Prothena Corp shares in Q2 2024, an estimated $245K.
  • Aigen Investment Management first reported a position in Prothena Corp in Q3 2020 and held it in 4 quarters.
  • Aigen Investment Management's Prothena Corp position peaked at $1.68M in Q3 2023.
  • 160 funds tracked by Wall St. Rank held Prothena Corp as of Q2 2024.

Based on Aigen Investment Management's 13F filing for Q2 2024, filed 9 Aug 2024.